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Abstract 62 
Breast-milk long-chain polyunsaturated fatty acids (LCPUFA) have been associated with changes 63 
in early life immune responses and may modulate T-cell function in infancy. We studied the effect 64 
of maternal fatty acid desaturase (FADS) genotype and breast-milk LCPUFA levels on infant’s 65 
blood T cell profiles and ex vivo produced cytokines after anti-CD3/CD28-stimulation of PBMCs in 66 
6 months old infants from the COPSAC2000 birth cohort. LCPUFA concentrations of breast-milk 67 
were assessed at 4 weeks of age and FADS single nucleotide polymorphisms (SNPs) were 68 
determined in both mothers and infants (n=109). In general, breast milk arachidonic acid (AA) 69 
levels were inversely correlated with the production of IL-10 (r=-0.25; p=0.004), IL-17 (r=-0.24; 70 
p=0.005), IL-5 (r=-0.21; p=0.014), and IL-13 (r=-0.17; p=0.047), while eicosapentaenoic acid 71 
(EPA) was positively correlated with the counts of blood Treg and cytotoxic T-cells, and decreased 72 
T helper cell counts. The minor FADS allele was associated with lower breast-milk AA and EPA, 73 
and infants of mothers carrying the minor allele of FADS SNP rs174556 had higher production of 74 
IL-10 (r=-0.23; p=0.018), IL-17 (r=-0.25; p=0.009) and IL-5 (r=-0.21; p=0.038) from ex vivo 75 
activated  immune cells. We observed no association between T-cell distribution and maternal or 76 
infant FADS gene variants. We conclude that increased maternal LCPUFA synthesis and breast-77 
milk AA is associated with decreased levels of IL-5, IL-13 (Type 2 related), IL-17 (Type 17-78 
related) and IL-10 (regulatory immune responses), but not to IFN-γ and TNF-α, which could be due 79 
to an unconfounded effect of the maternal FADS variants on the offspring immune response being 80 
transferred via breast milk LCPUFA.   81 
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Introduction 82 
Long-chain polyunsaturated fatty acids (LCPUFA) in breast-milk, specifically arachidonic acid 83 
(AA, 20:4 n-6) and docosahexaenoic acid (DHA, 22:6 n-3), may have beneficial effects on the 84 
development of the immune system in breastfed infants (1). This is speculated because LCPUFA’s 85 
are precursors of a range of immune-modulating signaling molecules (2,3). The diet is the most 86 
important determinant of breast-milk LCPUFA content (4), but the content is also affected by the 87 
maternal capacity to convert the precursor molecules to LCPUFA products (5,6) catalyzed by 88 
desaturases and elongases.  89 
Studies have reported that especially marine n-3 LCPUFA can modify immunological responses 90 
and change the Th1/Th2 balance  [7,8] also in infants [9,8,10] It has been suggested that such alterations 91 
might have an epigenetic origin [11] thus imposing more sustained changes on the immunological 92 
phenotype. In vitro studies have further confirmed the effect of LCPUFAs on cytokine production 93 
and proliferation of T-cells [12].  94 
Maternal intake of PUFA during lactation has been shown to modulate breast-milk DHA 95 
content and the immune responses in infants in a number of observational as well as a few 96 
randomized controlled trials (11–14). However, assessing diet is connected to a high risk of 97 
confounding interactions and the randomized trials have not been conclusive. Moreover, to our 98 
knowledge, no one has reported on the influence of LCPUFA in breast-milk in relation to other than 99 
Th1 and Th2  based responses, such as the IL-17-producing Th17, and IL-10 from regulatory T-100 
cells (Treg). Since most cytokines are produced by more than one cell type within peripheral blood 101 
mononuclear cells, we will use the terms Type 1 immune responses to refer to cytokines produced 102 
by Th1, cytotoxic T-cells, Natural Killer (NK) cells and innate lymphoid cells (ILC) type 1 (ILC1) 103 
with cardinal cytokines being interferon gamma (IFN-γ) and tumor necrosis factor alpha (TNF-α), 104 
while Type 2 responses are based on Th2 cells and ILC2 and the cytokines IL-4, IL-5 and IL-13. 105 
Type 17 responses are based on Th17 and ILC3 producing IL-17A, and regulatory type responses 106 
on regulatory T cells (Treg) and regulatory dendritic cells and monocytes, all producing IL-10. 107 
Recent studies have shown that single nucleotide polymorphisms (SNPs) in the fatty acid desaturase 108 
gene cluster (FADS) can affect maternal plasma and breast-milk PUFA composition (15,16). As the 109 
genetic variants are “randomized” during meiosis, the FADS SNPs can serve as a randomizing 110 
instrument independent of possible confounders (17).FADS have been shown to modify the effect 111 
of dietary fatty acid intake on health, that including the allergic diseases in children [20]. Moreover, 112 
it has been shown that the polymorphism of FADS genes can influence markers of the metabolic 113 
syndrome, and was demonstrated to influence the plasma total cholesterol, High and Density Lipids 114 
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and triglycerides levels in children [21,22] and therefore modulate the risk of cardiovascular diseases 115 
later in life. Further, these genes have been linked to neurodevelopmental outcomes in breastfed, 116 
although the results are still not unequivocal [5,6,23,24]. Also in relation to the breast milk 117 
composition, FADS genes seem to alter the effect of breastfeeding on risk of asthma, and for the 118 
homozygotes of the major allele no significant effect of breastfeeding on the development of asthma 119 
have been shown [25] 120 
The aim of this study was to analyze the influence of maternal FADS SNPs on the profile and 121 
function of T-cells isolated from infants at 6 months of age enrolled in the COPSAC2000 birth 122 
cohort. We also analyzed the associations between maternal FADS SNPs and breast-milk LCPUFA 123 
content as well as the association between breast-milk LCPUFA levels and infant immune 124 
responses. 125 
Methods and materials 126 
Cohort  127 
The Copenhagen Prospective Study of Asthma in Childhood (COPSAC2000) is a single-center, 128 
birth cohort study, with the objective to assess the interaction between genes and environment in 129 
infants and young children with high-risk of asthma to identify early-life exposures with a putative 130 
role in the development and course of atopic diseases. The cohort consists of 411 children of 131 
mothers with asthma recruited between 1998 and 2001. Premature children (gestational age <36 132 
weeks) as well as children suspected of chronic diseases or lung symptoms prior to inclusion were 133 
excluded. The COPSAC study is conducted in accordance with the Declaration of Helsinki and is 134 
approved by the Copenhagen Ethics Committee (KF 01-289/96 and KF 11-107/02) and the Danish 135 
Data Protection Agency (2008-41-1754). Oral and written informed consent was obtained from 136 
both parents at enrollment (18). 137 
Breast-milk samples 138 
Breast-milk samples (2-5ml) were collected at approximately four weeks post-partum. After 139 
addition of 0.01% 2.6-di-tert-butyl-4-methylphenol (Sigma Chemical Co, St Louis, MO), the 140 
breast-milk aliquots were frozen at -80°C. The analyses of the samples were completed within one 141 
year after the collection. The FA composition of the breast-milk was determined by extraction, 142 
KOH-catalyzed trans-methylation, gas-liquid chromatography (Hewlett-Packard Inc., Waldbronn, 143 
Germany) and use of commercial standards (Nu-Chek-Prep Inc, Elysian, MN) as previously 144 
described (19). Total values of the n-3 and n-6 PUFA families as well as the total of PUFAs were 145 
calculated using the full set of 11 PUFAs (19), but in this study we focused on LA, γ-linolenic acid 146 
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(GLA, 18:3 n-6), dihomo-γ-linolenic acid (dGLA, 20:3 n-6), AA, ALA, eicosapentaenoic acid 147 
(EPA, 20:5 n-3) and DHA. 148 
T cell phenotyping 149 
Peripheral blood mononuclear cells (PBMCs) were isolated by density centrifugation from 4ml 150 
peripheral blood drawn at the 6-month routine visit (mean age at the visit 6.35, SD=0.64) to the 151 
clinical research unit. The PBMCs were stored at -140°C for up to 12 years until the cells were 152 
analyzed during 2011. The overall composition of the T-cell compartment in PBMCs was assessed 153 
using flow cytometry with a predefined gating strategy: Cytotoxic T-cells (Tc; CD3+CD8+), T-154 
helper cells (Th; CD3+CD4+), and regulatory T-cells (Treg; CD3+CD4+CD127loCD25hi). The 155 
fraction of Tc- and Th-cells were calculated relative to total CD3+ cells, and Treg cells relative to 156 
CD3+CD4+ cells. Briefly, the methodology was as follows: Unstimulated PBMCs (5 x 105 cells) 157 
were washed once in FACS buffer (PBS containing 0.1% Sodium Azide and 1% heat-inactivated 158 
fetal bovine serum). Cells were stained with a pre-titrated fluorochrome-conjugated antibody 159 
mixture designed to characterize the T-cell compartment (CD3/eFlour450 (clone UCHT1), 160 
CD8/FITC (clone OKT8), CD127/APC-eFlour780 (clone A7R34) (all from eBioscience; San 161 
Diego, CA), and CD4/V500 (clone RPA-T4, BD Biosciences, San Jose, CA), CD25/PC7 (clone 162 
B1.49.9, Beckman Coulter, Brea, CA). 400,000 cells were analyzed on a BD FACSCanto™ II flow 163 
cytometer (BD Biosciences, Franklin Lakes, CA). 164 
Polyclonal T-cell activation and cytokine analysis 165 
PBMC (>95 % viable) were cultured in a concentration of 2x105 cells/200ul culture medium (RPMI 166 
1640 containing 2mM L-glutamine (Cambrex, East Rutherford, NJ); 0.1M HEPES (Lonza); 167 
100U/ml penicillin/streptomycin (Lonza) and 10% heat-inactivated fetal bovine serum (Cambrex)) 168 
in U-bottomed 96-well plates. T-cells were activated polyclonally by anti-CD3/28 expander beads 169 
(Dynabeads Human T-Activator CD3/CD28, Invitrogen) added at a beads-to-cell ratio of 1:2. 170 
Unstimulated cells were added culture medium alone. The PBMCs were stimulated for 40 hours in 171 
a humidified 37°C, 5% CO2 incubator and the response was assessed as cytokine production in 172 
cell-free culture supernatants. Supernatant cytokines interferon-gamma (IFN-γ), tumor necrosis 173 
factor-alpha (TNF-α), interleukin (IL)-17A, IL-5, IL-13, IL-10 and IL-2 were analyzed using a 174 
custom multiplex assay from Meso Scale Discovery, and read on a Sector Imager 6000 (MSD, 175 
Gaithersburg, MD, USA). The cytokine levels detected in unstimulated PBMCs were subtracted 176 
from that of activated cells. All concentrations were above zero, also upon adjustment for 177 
background cytokine production. 178 
FADS gene variants 179 
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Using a QIAamp DNA Blood Maxi Kit (QiagenInc, Valencia, CA), DNA was purified from blood 180 
samples of children and parents and stored at -80°C. Genotyping was performed in both the child 181 
and mothers, by high throughput genome-wide SNP genotyping, using the IlluminaInfinium II 182 
HumanHap550 BeadChip technology (Illumina, San Diego) as described previously (20–22) and 183 
hereafter imputed by use of the 1000 genomes reference CEU panel as previously described [31]. 184 
Five candidate SNPs were chosen based on previous studies (23) shown to be associated with PUFA 185 
metabolism. To reduce redundancy and because these SNPs are highly correlated (all in linkage 186 
with r2>0.5), we took forward rs174546 and rs174556, the two SNPs that were originally genotyped 187 
while the remaing three were purely imputed. The two SNPs furthermore had a high degree of 188 
linkage disequilibrium with each other (r2=0.866).   189 
Data handling and statistics  190 
From the COPSAC2000 cohort of 411 children, 90 infants were excluded as they were not breastfed 191 
more than one month (n=38) or their mothers failed to provide a breast-milk sample (n=52). A 192 
further 190 infants did not have data on T-cell immunology, leaving 131 infants with complete milk 193 
and T-cell immunology data. Of these, genotyping data was unavailable in 22 mothers, resulting in 194 
109 with complete data (Supplemental Figure 1).  195 
Samples were handled in a random manner by the researchers performing the laboratory analyses. 196 
Results are presented as mean±SD or median (25-75 percentile) for normally and non-normally 197 
distributed data, respectively. Due to non-normal distribution of the cytokines, all correlations 198 
between breast-milk PUFAs, FADS SNPs, cytokines and T-cell distribution were tested using the 199 
non-parametric Spearman method. SNPs were analyzed in additive genetic models (effect per minor 200 
allele). For tables genotypes were converted to best guess genotypes. The statistical data analysis 201 
was performed with SPSS (version 20.0; SPSS Inc, Chicago, IL). To examine the patterns in the 202 
cytokine profile we used Principal Component Analysis (PCA) performed using Matlab (version 203 
2013a; Mathworks) and subsequently used the two first principal components as continuous 204 
variables. Spearman correlations were used also to study correlations of the PCA scores and the 205 
FAs, T-cells count and SNPs. The content of individual FAs are presented as a percentage by 206 
weight of total FA content (FA%).Microsoft Office Excel 2007 software was used to create the 207 
heat-maps illustrating the correlation patterns between breast-milk PUFA, FADS SNPs and 208 
cytokines. The results were considered significant at the level p≤0.05.  209 
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Results 210 
The baseline description of the study population compared to the infants with incomplete data is 211 
shown in Table 2.  212 
Infant immune profiles at 6 months of age 213 
The T-cell phenotype distribution and mean ex vivo cytokine production after polyclonal activation 214 
in infants at 6 months of age are represented in Table 1. The overall infant cytokine response was 215 
analyzed by use of a multivariate principal component analysis (PCA) and the two principal 216 
components (PC1 and PC2) were found to explain 74% and 8.5% of the variation, respectively. 217 
PC1 separated the infants based on the overall level of cytokines produced, whereas PC2 segregated 218 
infants with a profile dominated by IFN-γ (Type 1) and IL-2 from infants with a profile associated 219 
mainly with IL-5 and IL-13 (Type 2), IL-17 (Type 17) and IL-10 (Regulatory cells) (Figure 1a). 220 
We analyzed the overall cytokine profile in the infants in relation to the maternal FADS genotype 221 
by color-coding according to the rs172556 gene variants. Some clustering of the infant cytokine 222 
profiles appeared based on maternal FADS genotype, and PC1 (overall cytokine level) correlated 223 
significantly with maternal gene variants of rs174556 (Figure 1b and Figure 2). The separation 224 
was however far from complete and the associations was studied further by univariate correlation 225 
analysis. 226 
Maternal FADS SNP effects on immunological responses in infants 227 
All individual cytokines were negatively correlated with the maternal FADS SNPs (Figure 2 and 228 
Supplemental Figure 2); and the correlations were significant for IL-17 vs. both FADS, and for IL-229 
10, IL-5 and PC1 (which is a score for all cytokines production) with rs174556. No significant 230 
correlation was found between FADS SNPs in the infants and the ex vivo induced cytokine 231 
production (Figure 2). 232 
Breast-milk concentrations of PUFAs 233 
The overall FA composition of the breast-milk was 42.0±4.3 FA% saturated fatty acids, 40.5±3.4 234 
FA% monounsaturated fatty acids and the mean total content of PUFAs was 13.7±2.6 FA% with a 235 
n-6/n-3 PUFA-ratio of 6.0±1.8. The breast-milk PUFA distribution was associated with the 236 
maternal FADS SNPs (Table 3), as minor allele carrying mothers of both SNPs had lower AA 237 
levels in their breast-milk. The breast-milk level of EPA was also decreased in minor allele carriers 238 
of rs174546 and tended to be so for rs174556, whereas no significant effects were seen on other 239 
PUFAs. Notably, none of the PUFAs were found to be highest in breast-milk from minor allele 240 
carriers.  241 
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Breast-milk PUFA and immunological response in infants 242 
Univariate correlation analyses of breast-milk PUFAs and ex vivo produced cytokines revealed that 243 
generally breast-milk PUFAs were inversely associated with the cytokine production, except for 244 
breast-milk EPA that was significantly associated with an increased number of Tc and less Th cells 245 
and associated (although not significantly) with increased cytokine secretion from activated T-cells 246 
(Figure 2). AA was inversely correlated with IL-10, IL-17, IL-5, and IL-13, and GLA was inversely 247 
correlated with IL-17, IL-5, and IL-13.  248 
When analyzing correlations between the relative numbers of Tc, Th and Treg in blood from the 249 
infants and maternal breast-milk PUFAs, we found an overall negative correlation between all 250 
breast-milk PUFAs and Treg counts; which was significant for dGLA and total n-6 PUFAs (Figure 251 
2 and Supplemental Figure 2). As expected, PUFAs showed opposing correlations with %Tc and 252 
%Th, but this was only significant for EPA, which was negatively correlated with %Th and 253 
positively correlated with %Tc (Figure 2 and Supplemental Figure 2). The combined cytokine 254 
profile from PC1 (Figure 1a and 1b) revealed a significant inverse correlation with breast-milk GLA 255 
and AA, whereas PC2 was positively correlated with dGLA, but not with any other of the studied 256 
breast-milk PUFAs (Figure 2 and Supplemental Figure 2).   257 
11 
 
Discussion 258 
Our results showed that infants of mothers carrying minor alleles of FADS rs174556 had higher ex 259 
vivo stimulated production of IL-10, IL-17 and IL-5 from PBMCs. We also found that higher 260 
breast-milk LCPUFA content was generally associated with lower infant cytokine production. The 261 
association was significant for AA and GLA levels, and IL-5 and IL-13, IL-17 and IL-10 (), but not 262 
for IFN-γ. AA levels in breast-milk were associated with maternal FADS gene variants.  263 
The main strength of our study is that unlike most studies on the role of PUFA in the regulation of 264 
infant immunological responses, our study did not include oil supplementation, but rather focused 265 
on maternal FADS genotype and natural LCPUFA concentrations in the breast-milk. Thus, our 266 
study simulated a randomized study using the genetic variants as a randomization variable 267 
independent of possible confounding factors (Mendelian Randomization Analysis). The accuracy of 268 
our findings would probably be improved if we had performed repeated breast-milk sampling, to 269 
rule out short-term fluctuations in LCPUFA content. Fluctuations are largest in the n-3 LCPUFAs 270 
that to a greater extent depend on the dietary intake (4) and thus also are more prone to confounding. 271 
One limitation of our study is the relatively small sample size. Moreover, the long-term storage of 272 
PBMCs have been shown to affect the ex vivo cytokine responses (24), but as all samples were stored 273 
in the same way, and we found viability to be >95%, this factor is  not likely to change the 274 
associations with maternal FADS and breast-milk PUFAs.  275 
We examined a large amount of associations, but did not correct for multiple testing due to the 276 
strong correlations between the cytokines and between the SNPs and LCPUFAs, which allows for 277 
treating them as non-independent variables; instead we focused on the consistency in the results to 278 
exclude type-1 errors. A high consistency observed in described correlations is unlikely to be the 279 
effect of chance. The same cytokines (IL-10, IL-5, IL-13 and IL-17) that showed to be significantly 280 
associated with the GLA and/or AA were also significantly associated (borderline tendency for IL-281 
13) with maternal SNP rs174556. Furthermore, we found more association than would be expected 282 
by chance. 283 
The breast-milk fatty acid composition was determined prospectively 5 month before the 284 
assessment of infant cytokine profile and a shorter period or simultaneous measurements might 285 
perhaps result in stronger associations. However, the time gap indicates that the effect of infant 286 
LCPUFA supply remains significant over time and that in utero or early PUFA intake may have a 287 
programming effect on the immune response. Randomized trials with maternal n-3 LCPUFA 288 
supplementation indicate that the former could be the most likely (25), while it cannot be neglected 289 
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that more long-lasting effects can be imposed on the immune system via epigenetic changes, as was 290 
previously demonstrated for n-3 LCPUFA in the study by Lee et al. (2013).  291 
FADS variants affect lipid metabolism and levels of specific PUFAs and served here as a 292 
randomization instrument, which indicated that the observed effect of maternal polymorphism on 293 
child’s immunity could be due to changes in the breast milk LCPUFA. Experimental studies are 294 
necessary to explore the putative causal effect of this association. Although both the associations 295 
between maternal FADS SNPs and breast-milk AA and breast-milk AA and infant ex vivo cytokine 296 
production were more pronounced than associations with any of the other LCPUFA, this does not 297 
necessarily indicate that the effect is due to AA. Other studies of maternal FADS polymorphism and 298 
the PUFA composition in breast-milk also indicate that the content of AA is influenced by FADS 299 
variants to a larger extent than that of n-3 LCPUFA (26,27). A longitudinal study of FADS variants 300 
and breast-milk PUFA found significant associations with AA and the AA/dGLA-ratio, but no 301 
associations for n-3 LCPUFA (28). However, Xie and Innis reported that FADS minor allele 302 
homozygotes had lower breast-milk levels of both AA and EPA, but one of the examined SNPs also 303 
decreased DHA (29) and another study reported lower proportions of breast-milk DHA in FADS 304 
minor allele homozygous mothers (30). FADS SNPs have been found to influence changes in the 305 
breast-milk fatty acid composition during the course of lactation, as the concentrations of saturated 306 
and trans-fatty acids increase markedly over time in the milk of minor allele carrying mothers, 307 
while no effect was seen on the time course in AA (28). Colostrum AA levels have also been found 308 
to be decreased in minor allele carriers of a number of FADS SNPs, but a few of the SNPs was also 309 
reported to result in a decrease in colostrum DHA (30). Furthermore, our recent study of FADS SNPs 310 
and LCPUFA status in infants showed that the effect of various SNPs may differ and vary over time 311 
(31). It is therefore, not possible to determine neither the timing of the effect nor the responsible 312 
LCPUFA from the current study.  313 
Studies on the role of breast-milk PUFA composition on offspring health have shown conflicting 314 
results (32–34). Most of the studies investigating the effect of dietary PUFAs on infant cytokine 315 
responses have focused on the effect of fish oil-supplementation. D’Vaz et al. (9) found that direct 316 
supplementation of the infants with fish oil from birth resulted in decreased Th2-responses (IL-13 317 
and IL-5) to allergens, and an increased polyclonal Th1-response as seen by increased IFN-γ and 318 
TNF-α, but no effect was seen on the IL-17 in response to mitogenic stimulation of PBMCs at 6 319 
months of age. Another study on a fish oil-supplementation of healthy infants from 9 to 12 month 320 
of age demonstrated higher IFN-γ  and a tendency for lower IL-10 production in stimulated whole-321 
blood cultures (35). An increased production of IFN-γ was also observed in lipopolysaccharide-322 
stimulated whole blood cultures from 2½-year-old children of mothers supplemented with fish oil 323 
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during the first 4 months of lactation, but there was no difference in the IL-10 production (36). In the 324 
present study, we observed significant changes in the production of IL-17, IL-5 and IL-13, which all 325 
correlated negatively with breast-milk AA and GLA.EPA was associated with an increase in the 326 
serum Tc% and concomitant decrease in Th as well as with an overall, although insignificant 327 
increase in the infant cytokine production. As Tc% also correlated positively with IFN-γ levels, it 328 
could be speculated that EPA may have an effect on T-cell immunology in the same direction as 329 
observed in the fish-oil supplementation studies. However, with the indicated opposing effect of 330 
EPA and AA and the enhancement of both EPA and AA by maternal FADS genotypes it will 331 
presumably be difficult to observe a significant effect of EPA under non-supplemented conditions. 332 
Regarding the potential effect of n-3 LCPUFA, the fact that the association with cytokine 333 
production was mainly seen for EPA, rather than DHA, does not mean that only EPA is promoting 334 
the effect, as EPA could merely be a better indicator of the variation in n-3 LCPUFA metabolism.  335 
Studies have indicated an association between infant FADS variants and the development of eczema 336 
and asthma (37–39). These variants have similarly been shown to alter the association between 337 
breastfeeding and risk of childhood asthma as well as the impact of dietary fatty acids on the risk of 338 
asthma, which has been shown to be strongest among homozygous major allele carriers (23,37). We 339 
speculate that the altered capacity of cytokine secretion might influence predisposition for 340 
development of immune-mediated diseases such as asthma. We have observed the association of 341 
breast-milk PUFAs to be strongest in regard to reduction of the cytokines mostly attributed to the 342 
activity of Type 2, Type 17 and regulatory responses as opposed to those from Type 1 responses . 343 
Aberrant Type 2 cell responses is commonly associated with asthmatic inflammation and 344 
additionally the Type 17 cytokines has been shown to enhance Type 2 cell mediated allergic 345 
inflammation, contributing to severe asthma (40). Our results therefore, suggest that the decrease of 346 
asthma and allergy risk by LCPUFA supply could be due to reduced Type 2 and  and Type 17  347 
activity in early life.  348 
In conclusion, our results indicate that maternal FADS SNPs through a higher infant supply of 349 
LCPUFA are associated with a decrease in the production of cytokines related to Type 2, Type 17 350 
and regulatory immune activity in the infant. Furthermore, our results indicate that breast-milk n-6 351 
and n-3 LCPUFA may have opposite effect and that breast-milk n-3 LCPUFA stimulate overall 352 
infant cytokine production. By changing the type of the immune cell  response, infant LCPUFA 353 
supply could modulate the susceptibility of the child to immune disorders, such as asthma and 354 
allergies, but further studies are necessary to elucidate the mechanisms. 355 
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Table 1. Infant blood T-cell counts (as percentage of CD3+ cells) and ex vivo stimulated cytokine 571 
production (pg/mL) at 6 month. 572 
Abbreviations: Tc- Cytotoxic T cell, Th- T helper cell, Treg- regulatory T cell, IFN- γ- Interferon 573 
gamma, TNF- α- Tumor Necrosis Factor alpha, IL- Interleukin. 574 
   575  
 
Median 25;75 percentile Min Max 
%Tc 25.8 20.8;31.5 11.3 43.1 
%Th 66.8 61.8;72.4 46.5 81.5 
%Treg of Th 3.3 2.7;4.0 0.8 6.7 
IFN-γ 743 409;1090 18.3 3270 
IL-2 16158 6914;24358 5.3 809539 
TNF-α 899 507;1360 19.0 2303 
IL-10 37.0 17.2;68.4 1.0 247.3 
IL-17 386 141;685 2.5 5136 
IL-5 8.0 2.7;16.8 0.1 135.2 
IL-13 207 87.8;387 0.3 1069 
21 
 
Table 2. Demographic characteristics of the studied infants and the rest of the COPSAC2000 birth 576 
cohort. 577 
    
Included 
(n=131) 
Not included 
(n=280) p 
Sex (% male) 51.1 48.6 0.6271 
Gestational age (weeks) 39.95±1.61 39.88±1.55 0.6342 
Birth weight (kg) 3.62±0.57 3.52±0.60 0.1092 
Birth length (cm) 52.48±2.22 52.21±2.36 0.2772 
Delivery (% natural, vacuum & cesarean) 62.6, 18.3 & 19.1 68.2, 10.4 & 21.4 0.080
1 
Apgar Score at 5 min (% ≥9) 95.3 97.1 0.3571 
Breastfed period (weeks) 36.5±20.9 40.7±33.6 0.1222 
Solely breastfed period (weeks) 21.7±25.6 39.3±50.2 <0.012 
Breastfed at blood sampling (% yes) 84 (64.1) 151 (53.9) 0.0551 
Solely breastfed at blood sampling (% 
yes) 13 (9.9) 12 (4.3) 0.044 
1 
Ethnicity (% Caucasian) 96.9 96.4 0.7871 
Mothers Education3 
Low 81 (63.3) 144 (57.8) 
0.5931 Medium 31 (24.2) 69 (27.7) 
University 16 (12.5) 36 (14.5) 
Mothers 
Occupation 
Unemployed 12 (9.4) 26 (10.2) 
0.0971 
Student 17 (13.4) 25 (9.8) 
Non-professional 37 (29.1) 91 (35.7) 
Professional 61 (48.0) 113 (44.3) 
Mothers age (years) 29.73±4.25 30.17±4.68 0.3642 
Fathers age (years) 31.71±5.00 31.52±5.25 0.7302 
 578 
Data are shown as mean±SD or n (%) 579 
1 Analyzed by Pearson's chi-squared test. 580 
2 Analyzed by independent samples T-test,  581 
3  Low (elementary school or college graduate), Medium (tradesman or medium 582 
length), High (university candidate).  583 
  584 
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Table 3. Breast-milk PUFA composition at 4 weeks post-partum in FADS SNP major allele 585 
homozygotes (MM), heterozygotes (Mm) and minor allele homozygotes (mm). 586 
 
mm Mm MM p 
rs174546 GG (n=15) CG (n=38) CC (n=56)   
LA1 9.29±2.03 9.57±2.08 10.04±2.05 0.342 
GLA2 0.12 (0.08;0.22) 0.12 (0.06; 0.19) 0.16 (0.09;0.26) 0.215 
dGLA2 0.41 (0.37;0.49) 0.41 (0.31;0.50) 0.41 (0.35;0.45) 0.927 
AA1 0.49±0.12 0.55±0.14 0.63±0.14 0.001 
Total n6 1 10.79±2.26 11.17±2.23 11.83±2.27 0.186 
ALA2 0.19 (0.79;1.33) 1.33 (1.02;1.61) 1.26 (0.98;1.48) 0.502 
EPA2 0.07 (0.00;0.10) 0.10 (0.07;0.16) 0.10 (0.08;0.15) 0.028 
DHA2 0.41 (0.28;0.47) 0.46 (0.31;0.60) 0.49 (0.36;0.66) 0.124 
Total n32 1.93 (1.49;2.10) 2.03 (1.70;2.55) 2.08 (1.71;2.60) 0.237 
rs174556 TT (n=14) TC (n=37) CC (n=58)   
LA1 9.17±2.05 9.72±2.04 9.95±2.08 0.443 
GLA2 0.13 (0.09;0.22) 0.12 (0.06;0.20) 0.16 (0.09;0.25) 0.310 
dGLA2 0.40 (0.36;0.50) 0.41 (0.31;0.50) 0.41 (0.34;0.45) 0.942 
AA1 0.50±0.12 0.54±0.14 0.62±0.13 0.001 
Total n6 1 10.70±2.32 11.32±2.19 11.73±2.30 0.283 
ALA2 1.22 (0.99; 1.39) 1.35 (0.98;1.62) 1.26 (0.97;1.47) 0.649 
EPA2 0.08 (0.04;0.10) 0.09 (0.07;0.17) 0.10 (0.08;0.15) 0.071 
DHA2 0.41 (0.31;0.48) 0.44 (0.30;0.60) 0.48 (0.36;0.65) 0.209 
Total n32 1.94 (1.51;2.10) 1.99 (1.70;2.55) 2.08 (1.71;2.55) 0.448 
Data are given as % by weight of all breast-milk fatty acids; means±SD or if not normally 587 
distributed as median (25;75 percentile).  588 
1 Statistical comparisons were performed by One-way ANOVA test. 589 
2 Statistical comparisons were performed by Kruskal-Wallis test.  590 
Abbreviations: LA- Linoleic Acid, GLA-gamma Linolenic Acid, dGLA- dihomo Gamma Linolenic 591 
Acid, AA- Arachidonic Acid, ALA- alpha Linolenic Acid, EPA- Eicosapentaenoic Acid, DHA- 592 
Decosahexaenoic Acid, PUFA- Polyunsaturated Fatty Acid.  593 
  594 
23 
 
Figures’ legends 595 
Figure 1. Multivariate principal component analysis of cytokines produced by ex vivo stimulation 596 
of infant PBMC at 6 month of age. The data are shown as the score plot displaying the dispersion of 597 
each individual (as each dot represents one individual) in regard to the combined production of the 598 
seven cytokines color-coded according to the maternal FADS rs172556 genotype (black, 599 
diamond=MM, light gray, square=Mm and dark gray, circle=mm). The cytokines separated as 600 
shown in the inserted loading plot. Variance explained by each component is placed on the axes. 601 
 602 
Figure 2. Heat-map illustrating the patterns in correlations between breast-milk PUFA, maternal 603 
and infants’ FADS variants (rows) and ex vivo induced cytokines, T-cell counts,  as well as 604 
combined cytokine profiles from PC1 and PC2, derived from Figure 2 (columns). White boxes 605 
represent negative correlations and black boxes positive correlations. The saturation of the color is a 606 
representation of the size of the Spearman correlation coefficients. Bold underlined values indicate 607 
that the correlation is statistically significant. Results are presented as correlation coefficient with 608 
the p value placed in the brackets below. 609 
 610 
 
